Synjardy XR 5 mg/1 (Empagliflozin, Metformin Hydrochloride TABLET, EXTENDED RELEASE) 5 mg/1

Synjardy XR 5 mg/1 combines empagliflozin and metformin hydrochloride for managing type 2 diabetes. This extended-release tablet supports blood sugar control when used as directed.

Strength

5 mg/1

Pack Size

60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0290-74)

Manufacturer / TM Owner

Boehringer Ingelheim Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Synjardy XR 5 mg/1 is designed to help manage type 2 diabetes by improving blood sugar levels. It is often used when diet and exercise alone are not sufficient. This medication works by combining two active ingredients, empagliflozin and metformin hydrochloride, to support glucose regulation. People may ask, 'What is Synjardy XR used for?' primarily in the context of type 2 diabetes management.

Side Effects

Common effects of Synjardy XR 5 mg/1 may include gastrointestinal discomfort, such as nausea or diarrhea, especially when first starting the medication. Some users may also experience urinary tract infections or low blood sugar levels. These effects can vary among individuals and typically subside as the body adjusts to the medication.

Precautions & Warnings

Synjardy XR 5 mg/1 should be handled with care, especially for those with kidney issues or a history of pancreatitis. It is important to stay hydrated and monitor blood sugar levels regularly. Always follow the advice of a healthcare provider regarding the use of this medication. Proper storage and adherence to prescribed guidelines are essential for safe use.

Avoid Interactions

Synjardy XR 5 mg/1 may interact with certain medications, including diuretics, insulin, and other diabetes treatments. Alcohol consumption should be avoided as it can increase the risk of low blood sugar. It is important to inform a healthcare provider about all medications being taken to avoid potential interactions. Always consult a healthcare professional before starting or stopping any medication.

Frequently Asked Questions

Synjardy XR 5 mg/1 is used to manage type 2 diabetes by helping to control blood sugar levels.

Synjardy XR 5 mg/1 should be taken orally, typically once daily, with food as directed by a healthcare provider.

Common side effects may include gastrointestinal discomfort, urinary tract infections, and low blood sugar levels.

It is important to consult a healthcare provider before taking Synjardy XR 5 mg/1 with other medications to avoid potential interactions.

Synjardy XR 5 mg/1 may not be suitable for everyone, especially those with certain medical conditions or allergies. Always consult a healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.